BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2580540)

  • 1. 4-(Indolyl-3)-1-(benzimidazolonylalkyl)-piperidines, a novel group of potential antiallergy compounds.
    Freter K; Fuchs V; Barsumian E; Oliver JT
    Arzneimittelforschung; 1985; 35(1A):272-6. PubMed ID: 2580540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of a new series of benzimidazoles as H1-antihistaminic agents.
    Cuberes MR; Contijoch M; Calvet C; Alegre J; Quintana JR; Frigola J
    Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1287-92. PubMed ID: 9301027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents.
    Iemura R; Kawashima T; Fukuda T; Ito K; Tsukamoto G
    J Med Chem; 1986 Jul; 29(7):1178-83. PubMed ID: 2879912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
    Carceller E; Merlos M; Giral M; Balsa D; Almansa C; BartrolĂ­ J; GarcĂ­a-Rafanell J; Forn J
    J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological studies on newly synthesized anti-allergic agents, 2-methyl-3-piperidino-beta-propionaphtone hydrochloride (KZ-111) and 3-isobutyryl-2-isopropylpyrazole-[1, 5-a] pyridine (KC-404).
    Nagai H; Iwamoto T; Nishiyori T; Takizawa T; Tsuchiya H; Koda A
    Jpn J Pharmacol; 1983 Dec; 33(6):1215-23. PubMed ID: 6199540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of benzimidazole derivatives with potential antihistaminic activity.
    Rida SM; el-Dine SA; Labouta IM
    Pharmazie; 1977 Oct; 32(10):577-9. PubMed ID: 24226
    [No Abstract]   [Full Text] [Related]  

  • 8. Conformationally restricted analogs of histamine H1 receptor antagonists: trans and cis-1-benzyl-3-dimethylamino-6-phenylpiperidine.
    Ahmed AE; Hanna PE; Grund VR
    J Med Chem; 1976 Jan; 19(1):117-22. PubMed ID: 1535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRL 22321, a compound that has mast cell stabilizing activity similar to that of disodium cromoglycate and in addition has smooth muscle relaxing activity.
    Spicer BA; Ross JW; Clarke GD; Harling EJ; Hassall PA; Smith H; Taylor JF
    Agents Actions; 1983 Jun; 13(4):301-9. PubMed ID: 6193695
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and antiallergy activity of 4-(diarylhydroxymethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
    Walsh DA; Franzyshen SK; Yanni JM
    J Med Chem; 1989 Jan; 32(1):105-18. PubMed ID: 2562852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioisosteric transformation of H1-antihistaminic benzimidazole derivatives.
    Iemura R; Hori M; Saito T; Ohtaka H
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2723-6. PubMed ID: 2575462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antihistaminic N-heterocyclic 4-piperidinamines. 1. Synthesis and antihistaminic activity of N-(4-piperidinyl)-1H-benzimidazol-2-amines.
    Janssens F; Torremans J; Janssen M; Stokbroekx RA; Luyckx M; Janssen PA
    J Med Chem; 1985 Dec; 28(12):1925-33. PubMed ID: 4068010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses of the metabolites of 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-1H benzimidazole difumarate (KG-2413) and related compounds.
    Iemura R; Hori M; Ohtaka H
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):962-6. PubMed ID: 2569942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K; Akagi M; Izushi K; Mio M
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2,4-Triazolo[4,3-a]quinoxaline-1,4-diones as antiallergic agents.
    Loev B; Musser JH; Brown RE; Jones H; Kahen R; Huang FC; Khandwala A; Sonnino-Goldman P; Leibowitz MJ
    J Med Chem; 1985 Mar; 28(3):363-6. PubMed ID: 2579236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11-Oxo-11H-pyrido[2,1-b]quinazoline-8-carboxylic acid, an orally active antiallergy agent.
    Schwender CF; Sunday BR; Herzig DJ
    J Med Chem; 1979 Jan; 22(1):114-6. PubMed ID: 423174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiallergic effects of a novel compound, SWR-00151].
    Tanaka Y; Masai E; Yashima T; Furukawa M
    Nihon Yakurigaku Zasshi; 1997 Apr; 109(4):193-206. PubMed ID: 9160349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.